ARTICLE | Company News
LibraGen Inc., sanofi-aventis deal
October 30, 2006 8:00 AM UTC
Under a two-phase deal, SAN will use LibraGen's microbial biodiversity technology to discover compounds derived from non-cultivable microorganisms to treat infectious diseases and cancer. LibraGen wil...